Camille ROESCH
Camille ROESCH
(Schaefer Izon)
Dr Camille Roesch is the Business Development Scientist for Izon Science Europe, and strongly
contributes to technical sales through demonstration of Izon's products and applications to our clients, her main responsibility being within the French market. In addition to these duties she also provides application and method development as well as support services for all European customers. Dr Roesch recently pened Izon's new French office in Lyon, that she will lead.
Before joining Izon Science Europe, Camille completed her PhD in Drug delivery, mainly focused on Nanotechnologies, at the University of Strasbourg in September 2013. Camille led the consultancy for the human health nanoregulatory strategy on behalf of the Australian Pesticides and Veterinary Medicines Authority and she is one of the authors of the Australian government’s human health and environmental risk assessment concept report. She is also co-author of 3 book chapters for the Merck Veterinary Manual, on ‘Drug action and Pharmacodynamics’, ‘Potential Uses of Nanotechnology in Veterinary Medicine’ and ‘Dosage Forms and Delivery Systems’.
